MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

    E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

    Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…
  • 2016 International Congress

    A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)

    V.K. Hinson, J. Elm, A. Delambo, T. Turner (Charleston, SC, USA)

    Objective: To evaluate (1) safety and tolerability of ATM and (2) effects of ATM on attention and executive functioning in PD- MCI after 10 weeks…
  • 2016 International Congress

    Finger tapping distance in idiopathic normal pressure hydrocephalus changes in parallel with frontal lobe function

    N. Nishida, Y. Sano, A. Kandori, H. Toda, S. Matsumoto, K. Iwasaki, M. Ishikawa (Osaka, Japan)

    Objective: We assessed upper extremity function of idiopathic normal pressure hydrocephalus (iNPH) patients by quantitative finger tapping test and checked the correlation with other clinical…
  • 2016 International Congress

    Correlations among motor, cognitive, and neuropsychiatric symptoms in Parkinson’s disease without dementia

    M. Gang, Y. Nishio, T. Baba, A. Takeda, E. Mori (Sendai, Japan)

    Objective: As a first step toward this aim, this study attempted to identify correlation patterns among the motor, cognitive, and neuropsychiatric symptoms in PD without…
  • 2016 International Congress

    Relationships of cognitive functions and psychiatric symptoms with motor phenotypes in patients with untreated early-stage Parkinson’s disease

    H. Terashi, Y. Ishimura, T. Taguchi, H. Mitoma, H. Aizawa (Tokyo, Japan)

    Objective: It has been shown that the clinical types of Parkinson's disease (PD) based on motor symptoms include motor phenotypes of postural instability and gait…
  • 2016 International Congress

    Chorea-acanthocytosis: The first described clinical case in Ukraine

    Y.O. Trufanov (Kyiv, Ukraine)

    Objective: The abstract provides a description of the clinical case of chorea-acanthocytosis diagnosed at the Department of Neurology No. 1 of the Kyiv Regional Clinical…
  • 2016 International Congress

    The effect of dopaminergic therapy on stimulus-response learning and decision-making in Parkinson’s disease using fMRI

    P.A. MacDonald, N.M. Hiebert, K.N. Seergobin, A.M. Owen (London, ON, Canada)

    Objective: Our aim was to examine the neural correlates of stimulus-response (SR) learning in patients with Parkinson's disease (PD) on and off dopaminergic (DA) therapy…
  • 2016 International Congress

    Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

    S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)

    Objective: To determine the discriminant ability of the Montreal Cognitive Assessment (MOCA) for detection of dementia or any cognitive impairment in patients with Parkinson's disease…
  • 2016 International Congress

    The relationship between cognitive aspects (education status, executive function and verbal fluency) and motor aspects (balance and gait) in patients with Parkinson’s disease

    C.O. Souza, M.C. Voos, H.F. Chien, D.V. Francato, A.F. Barbosa, J.M. Greve, E.T. Fonoff, E.R. Barbosa (Sao Paulo, Brazil)

    Objective: The aim of this study was to verify if there would be correlations between cognitive variables (educational status, executive function, verbal fluency) and motor…
  • 2016 International Congress

    Effects of a 12-week exercise program on cognition in Parkinson’s disease

    J.C. Johnson, A.L. Svitak, M.T. Farrell, S.C. Mosch, F. Yu, E.D. Parker, L.R. Hanson (Saint Paul, MN, USA)

    Objective: To evaluate the effectiveness of a 12-week vigorous exercise program to improve primarily cognition and secondarily motor function and quality of life in patients…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley